News from intrexon corporation

( Bloomberg:RTRKS,RICS:RTRKS)

Jul 01, 2014, 16:46 ET

Intrexon to Acquire Trans Ova Genetics

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into a definitive agreement to acquire Trans...

Jun 30, 2014, 08:30 ET

Intrexon's Industrial Products Division Achieves Bioconversion of Methane to Farnesene

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its Industrial Products Division has achieved the...

May 19, 2014, 08:30 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Names Christopher Basta Vice President of Investor Relations

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Christopher Basta as Vice President of...

May 12, 2014, 17:23 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon to Present at the 2014 BIO World Congress on Industrial Biotechnology

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Robert Walsh, Senior Vice President of Intrexon's Energy...

May 07, 2014, 17:00 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Announces First Quarter Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its first quarter results for 2014.  First Quarter...

Apr 16, 2014, 15:17 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Appoints Former Ernst & Young CEO James S. Turley to Board of Directors

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of James S. Turley to its Board of Directors,...

Mar 31, 2014, 16:30 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Announces Annual Report and Fourth Quarter Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its 2013 annual and fourth quarter results for 2013. ...

Mar 27, 2014, 13:44 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Forms Energy Collaboration for Gas-to-Liquids Bioconversion

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the formation of Intrexon Energy Partners (IEP), a joint venture...

Mar 17, 2014, 08:30 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Names Dr. Samuel Broder as Executive Vice President of Scientific and Public Affairs

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Samuel Broder, M.D., most recently Chairman of...

Mar 13, 2014, 16:30 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Acquires Laboratory Operations from Codexis and Expands Presence to Europe

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has acquired state-of-the-art laboratory operations...

Mar 12, 2014, 08:30 ET

Intrexon Appoints Dr. Kelly Huang as Head of Newly Established Consumer Sector

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Kelly Huang, Ph.D., most recently...

Mar 11, 2014, 08:30 ET

Intrexon to Present at the 2014 Barclays Global Healthcare Conference

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Krish Krishnan, Chief Operating Officer of Intrexon, will...

Mar 10, 2014, 08:30 ET

Amneal and Intrexon Enter into Exclusive Channel Collaboration to Improve Active Pharmaceutical Ingredient Production

 Amneal Pharmaceuticals LLC, the seventh largest generic drug manufacturer by volume in the U.S., and Intrexon Corporation (NYSE: XON), a...

Mar 07, 2014, 08:30 ET

Intrexon Completes Acquisition of Medistem

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has completed the acquisition of San Diego-based...

Mar 04, 2014, 08:30 ET

Intrexon Strengthens Leadership to Further Advance Company's Environment Sector

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Nir Nimrodi, currently Vice President and...

Feb 03, 2014, 08:30 ET

Intrexon to Present at the 2014 BIO CEO & Investor Conference

 Intrexon Corporation, (NYSE: XON), a leader in synthetic biology, announced today that Krish Krishnan, Chief Operating Officer of Intrexon,...

Jan 13, 2014, 08:30 ET

Fibrocell Science and Intrexon Expand Collaboration to Include Hypermobility-Type Ehlers-Danlos Syndrome

 Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for skin...

Jan 07, 2014, 16:39 ET

Intrexon to Present at the 2014 J.P. Morgan Healthcare Conference

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer of...

Dec 31, 2013, 08:30 ET

Agilis Biotherapeutics and Intrexon to Pursue Transformative Therapies for Rare Genetic Disease

 Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on rare genetic diseases, and Intrexon Corporation (NYSE: XON), a...

Dec 30, 2013, 08:30 ET

Intrexon Announces a Research and Development Collaboration with Johnson & Johnson Innovation to Advance New Skin and Hair Products

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered into a research and development...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer